Bandingkan Harga & Kinerja Sumi Indo Kabel Tbk. (IKBI) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Sumi Indo Kabel Tbk. dan Organon Pharma Indonesia Tbk.: Sumi Indo Kabel Tbk. diperdagangkan di Rp555 (kapitalisasi pasar 691,56 M, volume 24 jam 1,4 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Sumi Indo Kabel Tbk. jauh lebih besar — sekitar 6,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| IKBI | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 691,56 M | 104,4 M |
Volume | 1,4 jt | — |
Lot | 14,02 rb | — |
Perputaran | 779,16 jt | — |
Harga Rata-rata | 555,91 | — |
Nilai Transaksi | 779,16 jt | — |
Harga Ekuilibrium Indikatif | 555 | — |
Volume Ekuilibrium Indikatif | 49 | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Sumi Indo Kabel Tbk.
The Company was established on July 23, 1981 with its Head Office and Factory located in Tangerang, West Java. The Company was listed in JSX and SSX in 1990. On 1994 the Company changed status of the Company to become Foreign Capital Investment (PMA), right after participation of Sumitomo Electric Industries, Ltd., Japan which is one of the biggest in the world in cable industry and PT Perdanamulia Ekasakti.
Selengkapnya di halaman IKBI →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
